Gazelle POC Analyzer

Gazelle POC Analyzer

Point-of-Care Detection of Beta Thalassemia and Sickle Cell Disease.

Convenient, Automated Testing For Beta Thalassemia and Sickle Cell Disease

Gazelle delivers rapid laboratory-quality results to facilitate early detection

Beta thalassemia and sickle cell disease (SCD) are life-threatening, genetic disorders that affect millions of people across the globe, many of whom could be helped with early testing.

The only point-of-care solution for detecting beta thalassemia

Populations at risk for beta thalassemia often lack access to or cannot afford expensive laboratory tests and may be misdiagnosed when symptoms begin to occur.

Gazelle Microchip Electrophoresis Operation

A 20 μL blood sample is lysed and applied to the cartridge, which is then placed into the reader for analysis.

 

Categories: ,

Description

Automated interpretation and ease-of use features

Gazelle steps the user through the preparation of the sample, then automatically analyzes the sample for
hemoglobin types and quantities. The interpreted results are displayed onscreen in 8 minutes.

Clinical Applications:

  • Sickle Cell Disease (SCD): Accurately differentiates between normal hemoglobin, sickle cell trait, and disease states (HbSS).
  • Beta Thalassemia: Detects beta-thalassemia traits, major, and intermedia variants with high sensitivity and specificity.
  • Resource-Limited Settings: Designed for rugged, decentralized environments and remote areas where conventional laboratory testing or HPLC is unavailable.

Related products